{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:46:25Z","timestamp":1793738785169,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012540","name":"Guangdong Province Introduction of Innovative R&D Team","doi-asserted-by":"publisher","award":["201001Y04675344"],"award-info":[{"award-number":["201001Y04675344"]}],"id":[{"id":"10.13039\/100012540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"publisher","award":["G619310007"],"award-info":[{"award-number":["G619310007"]}],"id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"crossref","award":["Dnr KAW 2019.0059"],"award-info":[{"award-number":["Dnr KAW 2019.0059"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish Association against Rheumatism","award":["R-858181"],"award-info":[{"award-number":["R-858181"]}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["Dnr2017-06104"],"award-info":[{"award-number":["Dnr2017-06104"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["Dnr 2017-05835"],"award-info":[{"award-number":["Dnr 2017-05835"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["Dnr 2015-02662"],"award-info":[{"award-number":["Dnr 2015-02662"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["Dnr 2016-00288"],"award-info":[{"award-number":["Dnr 2016-00288"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["Dnr 2015-06247"],"award-info":[{"award-number":["Dnr 2015-06247"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"crossref","award":["Dnr RB13-0156"],"award-info":[{"award-number":["Dnr RB13-0156"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"crossref","award":["C1051017"],"award-info":[{"award-number":["C1051017"]}],"id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Antibodies binding to cartilage proteins are present in the blood and synovial fluid of early rheumatoid arthritis patients. In order to develop animal models mimicking the human disease, we have characterized the arthritogenic capacity of monoclonal antibodies directed towards different joint proteins in the cartilage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Purified antibodies specific to unmodified or citrullinated collagen type II (CII), collagen type XI (CXI), and cartilage oligomeric matrix protein (COMP) were produced as culture supernatant, affinity purified, pooled as antibody cocktails (Cab3 and Cab4), and injected intravenously into mice to induce arthritis. An adjuvant (lipopolysaccharide or mannan) was subsequently injected intraperitoneally on either day 5 or day 60 to enhance arthritis. Antibody binding and complement activation on the cartilage surface were analyzed by immunohistochemical methods. Bone erosions and joint deformations were analyzed by histological assessments, enzyme-linked immunosorbent assays, and micro-CT. Luminex was used to detect CII-triple helical epitope-specific antibody responses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The new cartilage antibody cocktails induced an earlier and more severe disease than anti-CII antibody cocktail. Many of the mouse strains used developed severe arthritis with 3 antibodies, binding to collagen II, collagen XI, and cartilage oligomeric matrix protein (the Cab3 cocktail). Two new models of arthritis including Cab3-induced LPS-enhanced arthritis (lpsCAIA) and Cab3-induced mannan-enhanced arthritis (mCAIA) were established, causing severe bone erosions and bone loss, as well as epitope spreading of the B cell response. Cab4, with addition of an antibody to citrullinated collagen II, induced arthritis more efficiently in moderately susceptible C57BL\/6\u2009J mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The new mouse model for RA induced with cartilage antibodies allows studies of chronic development of arthritis and epitope spreading of the autoimmune response and bone erosion.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13075-020-02169-0","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T08:02:32Z","timestamp":1590307352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis"],"prefix":"10.1186","volume":"22","author":[{"given":"Yanpeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peibin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"L\u00f6nnblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Viljanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingze","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kutty Selva","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4969-2576","authenticated-orcid":false,"given":"Rikard","family":"Holmdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,24]]},"reference":[{"issue":"5","key":"2169_CR1","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1172\/JCI108382","volume":"57","author":"P Stastny","year":"1976","unstructured":"Stastny P. Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest. 1976;57(5):1148\u201357.","journal-title":"J Clin Invest"},{"issue":"3","key":"2169_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ng.1076","volume":"44","author":"S Raychaudhuri","year":"2012","unstructured":"Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet. 2012;44(3):291\u20136.","journal-title":"Nat Genet"},{"issue":"3","key":"2169_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrrheum.2018.10","volume":"14","author":"HU Scherer","year":"2018","unstructured":"Scherer HU, Huizinga TWJ, Kronke G, Schett G, Toes REM. The B cell response to citrullinated antigens in the development of rheumatoid arthritis. Nat Rev Rheumatol. 2018;14(3):157\u201369.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"2169_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng1058","volume":"33","author":"P Olofsson","year":"2003","unstructured":"Olofsson P, Holmberg J, Tordsson J, Lu S, \u00c5kerstr\u00f6m B, Holmdahl R. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet. 2003;33(1):25\u201332.","journal-title":"Nat Genet"},{"issue":"34","key":"2169_CR5","doi-asserted-by":"publisher","first-page":"12646","DOI":"10.1073\/pnas.0403831101","volume":"101","author":"M Hultqvist","year":"2004","unstructured":"Hultqvist M, Olofsson P, Holmberg J, B\u00e4ckstr\u00f6m BT, Tordsson J, Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci U S A. 2004;101(34):12646\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2169_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1089\/ars.2011.4013","volume":"16","author":"Lina M. Olsson","year":"2012","unstructured":"Olsson LM, Nerstedt A, Lindqvist AK, Johansson AC, Medstrand P, Olofsson P, et al. Copy number variation of the gene NCF1 is associated with rheumatoid arthritis. Antioxid Redox Signal. 2012;16(1):71\u20138.","journal-title":"Antioxidants & Redox Signaling"},{"issue":"3","key":"2169_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ng.3782","volume":"49","author":"J Zhao","year":"2017","unstructured":"Zhao J, Ma J, Deng Y, Kelly JA, Kim K, Bang SY, et al. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nat Genet. 2017;49(3):433\u20137.","journal-title":"Nat Genet"},{"issue":"9","key":"2169_CR8","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/annrheumdis-2017-211287","volume":"76","author":"LM Olsson","year":"2017","unstructured":"Olsson LM, Johansson AC, Gullstrand B, Jonsen A, Saevarsdottir S, Ronnblom L, et al. A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus. Ann Rheum Dis. 2017;76(9):1607\u201313.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2169_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/art.1780280503","volume":"28","author":"K Aho","year":"1985","unstructured":"Aho K, Palosuo T, Raunio V, Puska P, Aromaa A, Salonen JT. When does rheumatoid disease start? Arthritis Rheum. 1985;28(5):485\u20139.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2169_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998;101(1):273\u201381.","journal-title":"J Clin Invest"},{"issue":"11","key":"2169_CR11","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/art.40562","volume":"70","author":"MK Verheul","year":"2018","unstructured":"Verheul MK, Bohringer S, van Delft MAM, Jones JD, Rigby WFC, Gan RW, et al. Triple positivity for anti-citrullinated protein autoantibodies, rheumatoid factor, and anti-carbamylated protein antibodies conferring high specificity for rheumatoid arthritis: implications for very early identification of at-risk individuals. Arthritis Rheumatol. 2018;70(11):1721\u201331.","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"2169_CR12","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2741\u20139.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2169_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/rheumatology\/40.2.205","volume":"40","author":"JC Edwards","year":"2001","unstructured":"Edwards JC, Cambridge G. Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford). 2001;40(2):205\u201311.","journal-title":"Rheumatology (Oxford)"},{"key":"2169_CR14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/jcp.33.11.1077","volume":"33","author":"HK Beard","year":"1980","unstructured":"Beard HK, Ryvar R, Skingle J, Greenbury CL. Anti-collagen antibodies in sera from rheumatoid arthritis patients. J Clin Pathol. 1980;33:1077\u201381.","journal-title":"J Clin Pathol"},{"issue":"5","key":"2169_CR15","first-page":"865","volume":"12","author":"PS Klimiuk","year":"1985","unstructured":"Klimiuk PS, Clague RB, Grennan DM, Dyer PA, Smeaton I, Harris R. Autoimmunity to native type II collagen--a distinct genetic subset of rheumatoid arthritis. J Rheumatol. 1985;12(5):865\u201370.","journal-title":"J Rheumatol"},{"issue":"8453","key":"2169_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0140-6736(85)90436-2","volume":"2","author":"RS Pereira","year":"1985","unstructured":"Pereira RS, Black CM, Duance VC, Jones VE, Jacoby RK, Welsh KI. Disappearing collagen antibodies in rheumatoid arthritis. Lancet. 1985;2(8453):501\u20132.","journal-title":"Lancet."},{"key":"2169_CR17","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/art.1780290314","volume":"29","author":"R Holmdahl","year":"1986","unstructured":"Holmdahl R, Rubin K, Klareskog L, Larsson E, Wigzell H. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum. 1986;29:400\u201310.","journal-title":"Arthritis Rheum"},{"key":"2169_CR18","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.4049\/jimmunol.148.7.2103","volume":"148","author":"K Terato","year":"1992","unstructured":"Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM. Induction of arthritis with monoclonal antibodies to collagen. J Immunol. 1992;148:2103\u20138.","journal-title":"J Immunol"},{"issue":"5","key":"2169_CR19","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0002-9440(10)63542-0","volume":"163","author":"KS Nandakumar","year":"2003","unstructured":"Nandakumar KS, Svensson L, Holmdahl R. Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol. 2003;163(5):1827\u201337.","journal-title":"Am J Pathol"},{"issue":"1","key":"2169_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jim.2009.01.009","volume":"343","author":"P Hutamekalin","year":"2009","unstructured":"Hutamekalin P, Saito T, Yamaki K, Mizutani N, Brand DD, Waritani T, et al. Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies. J Immunol Methods. 2009;343(1):49\u201355.","journal-title":"J Immunol Methods"},{"issue":"1\u20132","key":"2169_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jim.2005.06.017","volume":"304","author":"KS Nandakumar","year":"2005","unstructured":"Nandakumar KS, Holmdahl R. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. J Immunol Methods. 2005;304(1\u20132):126\u201336.","journal-title":"J Immunol Methods"},{"issue":"8","key":"2169_CR22","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.4049\/jimmunol.170.8.4318","volume":"170","author":"T Kagari","year":"2003","unstructured":"Kagari T, Tanaka D, Doi H, Shimozato T. Essential role of Fc gamma receptors in anti-type II collagen antibody-induced arthritis. J Immunol. 2003;170(8):4318\u201324.","journal-title":"J Immunol"},{"issue":"2","key":"2169_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1084\/jem.20081862","volume":"206","author":"H Uysal","year":"2009","unstructured":"Uysal H, Bockermann R, Nandakumar KS, Sehnert B, Bajtner E, Engstrom A, et al. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med. 2009;206(2):449\u201362.","journal-title":"J Exp Med"},{"key":"2169_CR24","doi-asserted-by":"crossref","unstructured":"Ge C, Tong D, Liang B, L\u00f6nnblom E, Schneider N, Hagert C, et al. Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage. JCI Insight. 2017;2(13):e93688.","DOI":"10.1172\/jci.insight.93688"},{"issue":"4","key":"2169_CR25","doi-asserted-by":"publisher","first-page":"R191","DOI":"10.1186\/ar4022","volume":"14","author":"H Geng","year":"2012","unstructured":"Geng H, Nandakumar KS, Pramhed A, Aspberg A, Mattsson R, Holmdahl R. Cartilage oligomeric matrix protein specific antibodies are pathogenic. Arthritis Res Ther. 2012;14(4):R191.","journal-title":"Arthritis Res Ther."},{"issue":"2","key":"2169_CR26","first-page":"147","volume":"37","author":"V Kouskoff","year":"1997","unstructured":"Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. A new mouse model of rheumatoid arthritis: organ-specific disease provoked by systemic autoimmunity. Ryumachi. 1997;37(2):147.","journal-title":"Ryumachi."},{"issue":"12","key":"2169_CR27","doi-asserted-by":"publisher","first-page":"7694","DOI":"10.4049\/jimmunol.172.12.7694","volume":"172","author":"BT Wipke","year":"2004","unstructured":"Wipke BT, Wang Z, Nagengast W, Reichert DE, Allen PM. Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J Immunol. 2004;172(12):7694\u2013702.","journal-title":"J Immunol"},{"key":"2169_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fimmu.2018.00451","volume":"9","author":"D Tong","year":"2018","unstructured":"Tong D, L\u00f6nnblom E, Yau ACY, Nandakumar KS, Liang B, Ge C, et al. A shared epitope of collagen type XI and type II is recognized by pathogenic antibodies in mice and humans with arthritis. Front Immunol. 2018;9:451.","journal-title":"Front Immunol"},{"issue":"1","key":"2169_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajpath.2012.03.031","volume":"181","author":"T Kelkka","year":"2012","unstructured":"Kelkka T, Hultqvist M, Nandakumar KS, Holmdahl R. Enhancement of antibody-induced arthritis via Toll-like receptor 2 stimulation is regulated by granulocyte reactive oxygen species. Am J Pathol. 2012;181(1):141\u201350.","journal-title":"Am J Pathol"},{"issue":"8","key":"2169_CR30","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/art.40482","volume":"70","author":"C Hagert","year":"2018","unstructured":"Hagert C, Sareila O, Kelkka T, Nandakumar KS, Collin M, Xu B, et al. Chronic active arthritis driven by macrophages without involvement of T cells: a novel experimental model of rheumatoid arthritis. Arthritis Rheumatol. 2018;70(8):1343\u201353.","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"2169_CR31","doi-asserted-by":"publisher","first-page":"R1148","DOI":"10.1186\/ar1800","volume":"7","author":"E Bajtner","year":"2005","unstructured":"Bajtner E, Nandakumar KS, Engstr\u00f6m \u00c5, Holmdahl R. Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen. Arthritis Res Ther. 2005;7(5):R1148\u201357.","journal-title":"Arthritis Res Ther."},{"key":"2169_CR32","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.4049\/jimmunol.157.6.2440","volume":"157","author":"JA Mo","year":"1996","unstructured":"Mo JA, Holmdahl R. The B cell response to autologous type II collagen: biased V gene repertoire with V gene sharing and epitope shift. J Immunol. 1996;157:2440\u20138.","journal-title":"J Immunol"},{"issue":"9","key":"2169_CR33","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1073\/pnas.84.9.2990","volume":"84","author":"C Juhlin","year":"1987","unstructured":"Juhlin C, Holmdahl R, Johansson H, Rastad J, \u00c5kerstr\u00f6m G, Klareskog L. Monoclonal antibodies with exclusive reactivity against parathyroid cells and tubule cells of the kidney. Proc Natl Acad Sci U S A. 1987;84(9):2990\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2169_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/276269a0","volume":"276","author":"M Shulman","year":"1978","unstructured":"Shulman M, Wilde CD, K\u00f6hler G. A better cell line for making hybridomas secreting specific antibodies. Nature. 1978;276:269\u201370.","journal-title":"Nature."},{"key":"2169_CR35","first-page":"215","volume-title":"Human genome methods","author":"R Holmdahl","year":"1998","unstructured":"Holmdahl R, Carlsen S, Mikulowska A, Vestberg M, Brunsberg U, Hansson A-S, et al. Genetic analysis of murine models for rheumatoid arthritis. In: Adolpho KW, editor. Human genome methods. New York: CRC press; 1998. p. 215\u201338."},{"issue":"2","key":"2169_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1365-3083.1994.tb03350.x","volume":"39","author":"JA Mo","year":"1994","unstructured":"Mo JA, Scheynius A, Nilsson S, Holmdahl R. Germline-encoded IgG antibodies bind mouse cartilage in vivo: epitope- and idiotype-specific binding and inhibition. Scand J Immunol. 1994;39(2):122\u201330.","journal-title":"Scand J Immunol"},{"issue":"3","key":"2169_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1084\/jem.20130968","volume":"211","author":"B Raposo","year":"2014","unstructured":"Raposo B, Dobritzsch D, Ge C, Ekman D, Xu B, Lindh I, et al. Epitope-specific antibody response is controlled by immunoglobulin V(H) polymorphisms. J Exp Med. 2014;211(3):405\u201311.","journal-title":"J Exp Med"},{"issue":"9","key":"2169_CR38","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/rheumatology\/31.9.583","volume":"31","author":"T Saxne","year":"1992","unstructured":"Saxne T, Heineg\u00e5rd D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol. 1992;31(9):583\u201391.","journal-title":"Br J Rheumatol"},{"issue":"5","key":"2169_CR39","first-page":"1675","volume":"149","author":"C Vingsbo","year":"1996","unstructured":"Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol. 1996;149(5):1675\u201383.","journal-title":"Am J Pathol"},{"issue":"1","key":"2169_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/art.23049","volume":"58","author":"KS Nandakumar","year":"2008","unstructured":"Nandakumar KS, Bajtner E, Hill L, Bohm B, Rowley MJ, Burkhardt H, et al. Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation. Arthritis Rheum. 2008;58(1):184\u201396.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2169_CR41","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/art.38383","volume":"66","author":"S Haag","year":"2014","unstructured":"Haag S, Schneider N, Mason DE, Tuncel J, Andersson IE, Peters EC, et al. Identification of new citrulline-specific autoantibodies, which bind to human arthritic cartilage, by mass spectrometric analysis of citrullinated type II collagen. Arthritis Rheumatol. 2014;66(6):1440\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"2169_CR42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41584-019-0244-4","volume":"15","author":"C Ge","year":"2019","unstructured":"Ge C, Holmdahl R. The structure, specificity and function of anti-citrullinated protein antibodies. Nat Rev Rheumatol. 2019;15(8):503\u20138.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"2169_CR43","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1186\/ar4605","volume":"16","author":"I Lindh","year":"2014","unstructured":"Lindh I, Snir O, Lonnblom E, Uysal H, Andersson I, Nandakumar KS, et al. Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice. Arthritis Res Ther. 2014;16(4):R143.","journal-title":"Arthritis Res Ther"},{"key":"2169_CR44","doi-asserted-by":"crossref","unstructured":"Farinotti A, Wigerblad G, Nascimento D, Bas DB, Urbina CM, Nandakumar KS, et al. Cartilage-binding antibodies induce pain through immune complex mediated stimulation of neurons. J Exp Med. 2019;216(8):1904\u20131924.","DOI":"10.1084\/jem.20181657"},{"issue":"5","key":"2169_CR45","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3109\/s10165-008-0080-x","volume":"18","author":"MJ Rowley","year":"2008","unstructured":"Rowley MJ, Nandakumar KS, Holmdahl R. The role of collagen antibodies in mediating arthritis. Mod Rheumatol. 2008;18(5):429\u201341.","journal-title":"Mod Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02169-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-020-02169-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02169-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T12:07:55Z","timestamp":1696162075000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02169-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,24]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2169"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02169-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,24]]},"assertion":[{"value":"14 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were conducted in accordance with the guidelines of the National Institutes of Health (NIH publication no. 8023) and approved by the ethics committee of Southern Medical University (L2020013).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RH is the inventor of a filed patent protecting the L10D9 and 15A11 antibodies. The other authors declare an absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}